CNS

Supporting Schizophrenia Clinical Trials: Keys to a Successful Study

What should sponsors take into consideration when planning a schizophrenia clinical trial & download PharPoint’s experience overview.

October 18, 2024
View the Post

Experience Overview: Supporting Alzheimer’s Disease Clinical Trials

Looking for a CRO to support an upcoming Alzheimer’s disease clinical trial? PharPoint’s experts work as an extension of your team to strategically plan, execute, and analyze Phase 1 – Phase 4 Alzheimer’s disease clinical trials.

September 28, 2022
View the Post

Alzheimer’s Disease & Decentralized Clinical Trials

Should your Alzheimer’s disease clinical trial be decentralized or include virtual aspects? In this article, we discuss potential benefits.

September 27, 2022
View the Post

4 Key Considerations for Managing & Monitoring Neurology Clinical Trials

Neurology studies are highly complex. Explore the following 4 key considerations to successfully manage and monitor neurology trials.

January 6, 2022
View the Post